ARDELYX, INC. Income Tax Paid State And Local After Refund Received
ARDELYX, INC. (ARDX) reported Income Tax Paid State And Local After Refund Received of $485.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxPaidStateAndLocalAfterRefundReceived · last filed 2026-02-19
- ARDELYX, INC. income tax paid state and local after refund received for fiscal 2025 was $485.00K, a 82.33% increase from fiscal 2024.
- ARDELYX, INC. income tax paid state and local after refund received for fiscal 2024 was $266.00K, a 421.57% increase from fiscal 2023.
- ARDELYX, INC. income tax paid state and local after refund received for fiscal 2023 was $51.00K.
| Period end | Income Tax Paid State And Local After Refund Received 12 month |
|---|---|
| 2025-12-31 | $485.00K 10-K · filed 2026-02-19 |
| 2024-12-31 | $266.00K 10-K · filed 2026-02-19 |
| 2023-12-31 | $51.00K 10-K · filed 2026-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |